EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma

Akihiro Kawatsuki, Hiroki Kobayashi, Shoka Kimura, Soichiro Fushimi, Yuki Doi, Yuki Fujiwara, Tomoko Yamasaki, Takeru Asano, Yasushi Hiramatsu

Journal of Clinical and Experimental Hematopathology · 2026 · 66 (1) · 63-68

DOI: 10.3960/jslrt.25065 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Akihiro Kawatsuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji-shi, Hyogo, Japan. Hauptthemen laut MEDLINE: Multiple Myeloma, Antibodies, Bispecific. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaAntibodies, BispecificHumansFemaleAgedDisease ProgressionTomography, X-Ray Computed

Stichwörter der Autor:innen

elranatamabmultiple myelomapseudoprogression

Substanzen

Antibodies, Bispecific

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji-shi, Hyogo, Japan.
  • Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Pathology, Japanese Red Cross Society Himeji Hospital, Himeji-shi, Hyogo, Japan.

Zitieren

APA

Kawatsuki, A., Kobayashi, H., Kimura, S., Fushimi, S., Doi, Y., Fujiwara, Y., Yamasaki, T., Asano, T., & Hiramatsu, Y. (2026). Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma. Journal of Clinical and Experimental Hematopathology, 66(1), 63-68. https://doi.org/10.3960/jslrt.25065

Vancouver

Kawatsuki A, Kobayashi H, Kimura S, Fushimi S, Doi Y, Fujiwara Y, et al. Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma. Journal of Clinical and Experimental Hematopathology. 2026;66(1):63-68. doi:10.3960/jslrt.25065

BibTeX
@article{Kawatsuki2026,
  author = {Kawatsuki, Akihiro and Kobayashi, Hiroki and Kimura, Shoka and Fushimi, Soichiro and Doi, Yuki and Fujiwara, Yuki and Yamasaki, Tomoko and Asano, Takeru and Hiramatsu, Yasushi},
  title = {Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2026},
  volume = {66},
  number = {1},
  pages = {63--68},
  doi = {10.3960/jslrt.25065}
}
Kostenlos starten →